Dasatinib Norameda

Medicinal product

(Invented) name

Dasatinib Norameda

Active substance (s)

Dazatinibas

Strength

50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EA02, dasatinib

Marketing authorisation holder

UAB Norameda, Lietuva

Date of authorisation

2020-02-10

Date of renewal

2024-03-14

Documents

4510-12_Dasat_Norameda_perr2024-03-14.docx

4510-12_pakuotes lapelis_2024-03-14.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/4592/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Dazatinibas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
103232	89333	1089333	lizdinė plokštelė	N56		Receptinis	LT/1/20/4511/001	Netiekiama	-	-	No	-	-
103233	89334	1089334	lizdinė plokštelė	N60		Receptinis	LT/1/20/4511/002	Netiekiama	-	-	No	-	-
103234	89335	1089335	dalomoji lizdinė plokštelė	N56x1		Receptinis	LT/1/20/4511/003	Netiekiama	-	-	No	-	-
103235	89336	1089336	dalomoji lizdinė plokštelė	N60x1		Receptinis	LT/1/20/4511/004	Netiekiama	2025-08-06	-	No	-	-	Download
103236	89337	1089337	talpyklė	N60		Receptinis	LT/1/20/4511/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-03-14	Perregistruotas
2020-02-10	Registruotas